Manage My Pain at Chronic Pain Clinics

Chronic Pain Clinical Trial

Official title:

Manage My Pain at Chronic Pain Clinics in Urban, Community, and Rural Hospitals

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04762329
• Other study ID #: 17-6201
• Status: Completed
• Phase: N/A
• Start date: January 8, 2018
• Est. completion date: April 8, 2020

Study information

• Verified date: February 2021
• Source: University Health Network, Toronto
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The overall objective of this Early Adoption project is to gather evidence for how Managing My Pain Program (MMP), a novel digital pain management application can enable better care at home for chronic pain sufferers in the province of Ontario, Canada across 4 sites in urban, community, and rural settings

Description:

Chronic pain imposes a large burden on individuals and society. A patient-centric digital chronic pain management application, Managing My Pain Program (MMP) that incorporates validated questionnaires can be used to enhance communication between providers and patients and promote self-management to evaluate the extent of patient engagement with the app when used in clinical settings.

The main objectives for this project is to evaluate the engagement in patients using MMP, and to assess improvements in clinical outcomes directly relevant for pain management, as measured by clinically-validated tools.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 246
• Est. completion date: April 8, 2020
• Est. primary completion date: January 8, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• New patients with chronic pain conditions referred to participating sites with pain programs to adopt the MMP tool into clinical practice.

Exclusion Criteria:

• Patients declining to consent for the study

• Patients withdrawing from the study at a later time after consenting

Related Conditions & MeSH terms

• Chronic Pain

Intervention

Other:
• Manage My Pain (MMP) digital pain app group
To evaluate the extent of patient engagement with the Manage My Pain (MMP) digital application when used in a clinical setting

Locations

Country	Name	City	State
Canada	Toronto Western Hospital	Toronto	Ontario

Sponsors (2)

Lead Sponsor	Collaborator
University Health Network, Toronto	Ontario Centres of Excellence

Country where clinical trial is conducted

Canada, 

References & Publications (3)

Alexander JC, Joshi GP. Smartphone applications for chronic pain management: a critical appraisal. J Pain Res. 2016 Sep 26;9:731-734. eCollection 2016. — View Citation

Portelli P, Eldred C. A quality review of smartphone applications for the management of pain. Br J Pain. 2016 Aug;10(3):135-40. doi: 10.1177/2049463716638700. Epub 2016 Apr 19. — View Citation

Salazar A, de Sola H, Failde I, Moral-Munoz JA. Measuring the Quality of Mobile Apps for the Management of Pain: Systematic Search and Evaluation Using the Mobile App Rating Scale. JMIR Mhealth Uhealth. 2018 Oct 25;6(10):e10718. doi: 10.2196/10718. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Evaluating engagement based on adoption and retention rates	Evaluating the number of patients who elected to use the Manage My Pain (MMP) application, and determining how long they used the app in the short-term (4.5 months) and long-term (4.5-7 months) follow-ups	24 months
Secondary	Change in depression as measured by the Patient Health Questionnaire 9-item (PHQ-9)		Short-term (4.5 months) and long-term (4.5-7 months)
Secondary	Change in anxiety as measured by the General Anxiety Disorder 7-item Questionnaire (GAD-7)		Short-term (4.5 months) and long-term (4.5-7 months)
Secondary	Change in pain disability as measured by the Pain Disability Index (PDI)		Short-term (4.5 months) and long-term (4.5-7 months)
Secondary	Change in pain catastrophizing and measured by the Pain Catastrophizing Scale (PCS)		Short-term (4.5 months) and long-term (4.5-7 months)
Secondary	Change in opioid consumption as measured by Oral Morphine Equivalents (OME)		Short-term (4.5 months) and long-term (4.5-7 months)
Secondary	Change in patient satisfaction as measured by the Patient Global Impression of Change (PGIC) scale		Short-term (4.5 months) and long-term (4.5-7 months)